Neutrophil Elastase Inhibitor Screening Assay Kit

SKU:BHT18200002
Overview
Click light‑blue chips for details
Neutrophil Elastase Inhibitor Screening Assay Kit from BPS Bioscience for quantification of neutrophil elastase (NE) activity and screening of NE inhibitors in 96-well or 384-well format. Suitable for HTS compound library screening and IC50 determination.
Target Enzyme Neutrophil Elastase (NE)
Format 96-well / 384-well HTS
Application Inhibitor Screening
Options selector
Catalog no. Size
82090-1 96 Reactions
82090-2 384 Reactions
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options — Size: 96 Reactions, 384 Reactions
  • Lead time: options listed as In Stock at Manufacturer typically ship after a short processing time; other statuses may take longer.
  • Storage: This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed.
  • Shipping: cold-chain shipment (typically with ice packs).
  • Upon receipt: store at recommended temperature as soon as possible.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No 82090
Alternative Names Bone marrow serine protease, Elastase-2, Human leukocyte elastase (HLE), Medullasin, PMN elastase, ELANE, ELA2
Product Type
  • Enzyme Activity Assay Kit
Shipping -80°C (dry ice)
Storage This assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed.
UniProt # P08246

Scientific Background

Elastase is a serine protease from the chymotrypsin family involved in the degradation of elastin and some viral proteins. Elastase exists as pancreatic and neutrophil elastase, which differ in their specificity. Neutrophil elastase is also known as ELA2 or polymorphonuclear leukocyte elastase and is present in azurophilic granules. Upon neutrophil activation, degranulation occurs and serine proteases, such as elastase, are released into the extracellular space to degrade the matrix proteins of pathogens. Alterations in the levels of elastase, or dysfunction of its endogenous inhibitors, result in alpha-1 antitrypsin deficiency (A1AD), emphysema, cyclic neutropenia, abdominal aortic aneurysms (AAA) and chronic obstructive pulmonary disease (COPD), arthritis and psoriasis. The use of neutrophil elastase inhibitors, such as elafin, and the development of new inhibitors with fewer side effects may benefit patients suffering from elastase-related diseases.

Product Description

The Neutrophil Elastase Inhibitor Screening Assay Kit is a fluorogenic assay designed to measure the activity of elastase for screening and profiling applications. The elastase assay kit comes in a convenient 96-well or 384-well format and contains enough purified elastase, fluorochrome-conjugated substrate, and PR-02 buffer for 100 or 400 reactions. This kit also includes Sivelestat as control inhibitor. PR Substrate 3 is a fluorogenic peptide substrate for neutrophil elastase. In the conjugated form the energy emitted from the fluorochrome AMP is quenched. Proteolysis releases AMP and fluorescence is emitted. The increase in fluorescence is directly proportional to elastase activity.

Methodology

Fluorogenic

Applications

Screen small molecule inhibitors in high throughput screening (HTS) applications.

Safety & Handling

For Research Use Only (RUO). Biosafety Level: Not applicable (BSL-1). Note: Troubleshooting Guide: Visit bpsbioscience.com/assay-kits-faq for detailed troubleshooting instructions. For all further questions, please email support@bpsbioscience.com Consult the Safety Data Sheet (SDS) before use.

Avoid freeze/thaw cycles.
StorageThis assay kit will perform optimally for up to 6 months from date of receipt when the materials are stored as directed.
Upon Receiptstore at recommended temperature as soon as possible.
Biosafety LevelNot applicable (BSL-1)
What is the principle of this assay?

This assay uses a fluorogenic or chromogenic peptide substrate that is cleaved by neutrophil elastase (NE), releasing a detectable signal proportional to enzyme activity. Inhibitor compounds reduce substrate cleavage, producing a dose-dependent decrease in signal. IC50 values are calculated from percent inhibition curves using non-linear regression.

Is this kit compatible with 384-well high-throughput screening?

Yes. This kit is available in both 96-well and 384-well formats, with the 384-well format (82090-2) specifically designed for high-throughput compound library screening. Miniaturized volumes reduce reagent consumption per data point and enable automated liquid handling for large-scale inhibitor screening campaigns.

What positive and negative controls are included?

The kit typically includes positive control (active NE enzyme), substrate, and assay buffer to establish a baseline signal. Researchers should include a known NE inhibitor as a positive inhibition control and a no-enzyme background well as a negative control in each plate to enable data normalization and Z'-factor calculation for HTS assay qualification.

Is this kit suitable for measuring NE activity in biological samples?

This kit is primarily designed for compound screening using recombinant NE. Measurement of NE activity in complex biological samples (e.g., bronchoalveolar lavage, sputum) may be possible but requires optimization to account for endogenous matrix effects, protease inhibitor carry-over, and background fluorescence. Validate sample compatibility before reporting data from biological matrices.

BioHippo partners with leading life science suppliers to offer flexible purchasing and support options. Contact our team to discuss the following add-on services.

  • Bulk & Volume Pricing: Reduced per-unit pricing for multi-unit or project-scale orders. Submit a quote request for a customized offer.
  • Expedited Fulfillment: Priority order handling may be available for time-sensitive projects. Confirm availability before ordering.
  • Technical Consultation: Our scientific team provides protocol guidance and troubleshooting at no additional charge.
  • Custom Configurations: Alternative formulations, pack sizes, or kit configurations may be available upon request.

Use the contact form or live chat on ebiohippo.com to connect with a product specialist.

  1. Jakimiuk K, et al., 2021 J Enzyme Inhib Med Chem 36(1): 1016-1028.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today